295 related articles for article (PubMed ID: 1351271)
1. Functionally distinct subpopulations of striatal neurons are differentially regulated by GABAergic and dopaminergic inputs--II. In vitro analysis.
Nisenbaum ES; Grace AA; Berger TW
Neuroscience; 1992; 48(3):579-93. PubMed ID: 1351271
[TBL] [Abstract][Full Text] [Related]
2. Functionally distinct subpopulations of striatal neurons are differentially regulated by GABAergic and dopaminergic inputs--I. In vivo analysis.
Nisenbaum ES; Berger TW
Neuroscience; 1992; 48(3):561-78. PubMed ID: 1318517
[TBL] [Abstract][Full Text] [Related]
3. Depression of glutamatergic and GABAergic synaptic responses in striatal spiny neurons by stimulation of presynaptic GABAB receptors.
Nisenbaum ES; Berger TW; Grace AA
Synapse; 1993 Jul; 14(3):221-42. PubMed ID: 8105549
[TBL] [Abstract][Full Text] [Related]
4. Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA(A) receptors in vivo.
Paladini CA; Celada P; Tepper JM
Neuroscience; 1999 Mar; 89(3):799-812. PubMed ID: 10199614
[TBL] [Abstract][Full Text] [Related]
5. Intracellular studies on the dopamine-induced firing inhibition of neostriatal neurons in vitro: evidence for D1 receptor involvement.
Calabresi P; Mercuri N; Stanzione P; Stefani A; Bernardi G
Neuroscience; 1987 Mar; 20(3):757-71. PubMed ID: 2955246
[TBL] [Abstract][Full Text] [Related]
6. Presynaptic modulation by GABAB receptors of glutamatergic excitation and GABAergic inhibition of neostriatal neurons.
Nisenbaum ES; Berger TW; Grace AA
J Neurophysiol; 1992 Feb; 67(2):477-81. PubMed ID: 1349038
[TBL] [Abstract][Full Text] [Related]
7. N-methyl-D-aspartate-evoked release of [3H]acetylcholine in striatal compartments of the rat: regulatory roles of dopamine and GABA.
Blanchet F; Kemel ML; Gauchy C; Desban M; Perez S; Glowinski J
Neuroscience; 1997 Nov; 81(1):113-27. PubMed ID: 9300405
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease.
Calabresi P; Mercuri NB; Sancesario G; Bernardi G
Brain; 1993 Apr; 116 ( Pt 2)():433-52. PubMed ID: 8096420
[TBL] [Abstract][Full Text] [Related]
9. Modulation of dopaminergic terminal excitability by D1 selective agents: further characterization.
Diana M; Young SJ; Groves PM
Neuroscience; 1991; 42(2):441-9. PubMed ID: 1680226
[TBL] [Abstract][Full Text] [Related]
10. In vivo release of [3H]gamma-aminobutyric acid in the rat neostriatum--II. Opposing effects of D1 and D2 dopamine receptor stimulation in the dorsal caudate putamen.
Girault JA; Spampinato U; Glowinski J; Besson MJ
Neuroscience; 1986 Dec; 19(4):1109-17. PubMed ID: 2950336
[TBL] [Abstract][Full Text] [Related]
11. The effects of intranigral GABA and dynorphin A injections on striatal dopamine and GABA release: evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors.
Reid MS; O'Connor WT; Herrera-Marschitz M; Ungerstedt U
Brain Res; 1990 Jun; 519(1-2):255-60. PubMed ID: 1975763
[TBL] [Abstract][Full Text] [Related]
12. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
13. A mechanism underlying dopamine D1 and D2 receptor-mediated inhibition of dopaminergic neurones in the ventral tegmental area in vitro.
Momiyama T; Todo N; Sasa M
Br J Pharmacol; 1993 Aug; 109(4):933-40. PubMed ID: 8104652
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory control of the GABAergic transmission in the rat neostriatum by D2 dopamine receptors.
Delgado A; Sierra A; Querejeta E; Valdiosera RF; Aceves J
Neuroscience; 2000; 95(4):1043-8. PubMed ID: 10682711
[TBL] [Abstract][Full Text] [Related]
15. Modulation of dopaminergic terminal excitability by D1 selective agents.
Diana M; Young SJ; Groves PM
Neuropharmacology; 1989 Jan; 28(1):99-101. PubMed ID: 2522599
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of striatal cell subtypes using in vivo intracellular recording in rats: II. Membrane factors underlying paired-pulse response profiles.
Onn SP; Berger TW; Grace AA
Synapse; 1994 Mar; 16(3):195-210. PubMed ID: 8197582
[TBL] [Abstract][Full Text] [Related]
17. Phosphodiesterase 10A controls D1-mediated facilitation of GABA release from striato-nigral projections under normal and dopamine-depleted conditions.
Mango D; Bonito-Oliva A; Ledonne A; Nisticò R; Castelli V; Giorgi M; Sancesario G; Fisone G; Berretta N; Mercuri NB
Neuropharmacology; 2014 Jan; 76 Pt A():127-36. PubMed ID: 23973317
[TBL] [Abstract][Full Text] [Related]
18. GABAergic afferents activate both GABAA and GABAB receptors in mouse substantia nigra dopaminergic neurons in vivo.
Brazhnik E; Shah F; Tepper JM
J Neurosci; 2008 Oct; 28(41):10386-98. PubMed ID: 18842898
[TBL] [Abstract][Full Text] [Related]
19. Long-term synaptic depression in the striatum: physiological and pharmacological characterization.
Calabresi P; Maj R; Pisani A; Mercuri NB; Bernardi G
J Neurosci; 1992 Nov; 12(11):4224-33. PubMed ID: 1359031
[TBL] [Abstract][Full Text] [Related]
20. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
Hu XT; Brooderson RJ; White FJ
Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
